Engineering Single-Chain Antibody Fragment (scFv) Variants Targeting A Disintegrin and Metalloproteinase-17 (ADAM-17).

Biomolecules · 2025 · PMC12838881 · PMID 41594573

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

The results revealed a clear trend indicating that non-binders to ADAM-17 are predominantly enriched in shorter CDR-H3 length compared to binders ( Figure 3 A).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.